Phase III study of AKP-01 spray in mild to moderate plaque psoriasis meets primary endpoint Jan. 27, 2020
PIKfyve inhibitors identified at MFMER, Sanford Burnham Prebys Medical Discovery Institute Jan. 27, 2020
RSS